ES268958A1 - Non-toxic antigens and process for producing same - Google Patents

Non-toxic antigens and process for producing same

Info

Publication number
ES268958A1
ES268958A1 ES0268958A ES268958A ES268958A1 ES 268958 A1 ES268958 A1 ES 268958A1 ES 0268958 A ES0268958 A ES 0268958A ES 268958 A ES268958 A ES 268958A ES 268958 A1 ES268958 A1 ES 268958A1
Authority
ES
Spain
Prior art keywords
toxic
protein
antigen
producing same
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0268958A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wander AG
Original Assignee
Wander AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wander AG filed Critical Wander AG
Publication of ES268958A1 publication Critical patent/ES268958A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A synthetic non-toxic antigen, which when used to inoculate a living organism is effective in producing antibodies against Gram-negative bacteria, has as a constituent of a determinant group thereof at least one 3,6-didesoxyhexose coupled to a protein which is physiologically acceptable by the organism to be inoculated. The 3,6-didesoxy-hexose may be abequose, colitose, tyvelose, paratose or ascarylose, and the protein may be serum albumin or serum globulin. The synthetic antigen may be applied together with a non-toxic pharmaceutical carrier such as a sterile isotonic aqueous solution containing a preservative. Specification 725,938 is referred to.
ES0268958A 1960-07-12 1961-07-10 Non-toxic antigens and process for producing same Expired ES268958A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH793560A CH396316A (en) 1960-07-12 1960-07-12 Process for the manufacture of vaccines

Publications (1)

Publication Number Publication Date
ES268958A1 true ES268958A1 (en) 1961-12-16

Family

ID=4332624

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0268958A Expired ES268958A1 (en) 1960-07-12 1961-07-10 Non-toxic antigens and process for producing same

Country Status (4)

Country Link
CH (1) CH396316A (en)
ES (1) ES268958A1 (en)
FR (1) FR1175M (en)
GB (1) GB916455A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8202527A (en) * 1982-06-22 1984-01-16 Univ Utrecht VACCINES AGAINST DISEASES AND PROCESS FOR PREPARING THESE BACTERIA WITH CAPSLE POLYSACCHARIDES.
US4663160A (en) * 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
US4486344A (en) * 1983-03-28 1984-12-04 Miles Laboratories, Inc. Urea-linked immunogens, antibodies, and preparative method

Also Published As

Publication number Publication date
FR1175M (en) 1962-03-12
GB916455A (en) 1963-01-23
CH396316A (en) 1965-07-31

Similar Documents

Publication Publication Date Title
GB1257263A (en)
ATE118787T1 (en) SYNTHETIC PEPTIDES USEFUL AS UNIVERSAL CARRIERS FOR THE PRODUCTION OF IMMUNOGENIC CONJUGATES AND THEIR USE IN THE DEVELOPMENT OF SYNTHETIC VACCINES.
FI103976B1 (en) Method for Diagnosis of Insulin Dependent Diabetes Mellitus (IDDM) in vitro, and Equipment and Polypeptide
GB1498081A (en) Covalently bound biological substances to plastic materials and use in radioassay
AU8172094A (en) Synthetic HTLV-III peptides, compositions and uses thereof
ATE866T1 (en) IMMUNE GERMINAL GLOBULIN (ISG) PREPARATIONS AND PROCESSES FOR THEIR MANUFACTURE.
GB1460522A (en) Process for the manufacture of antige-coated or antigen-coated or antigen-protein conjugate-coated erythrocytes
ATE7761T1 (en) VACCINE AND PRODUCTION PROCESS.
ATE24018T1 (en) POLYSACCHARID ANTIGENS FROM STREPTOCOCCUS AND VACCINES.
GB1418849A (en) Production of antisera
KR900005986A (en) Use of zinc hydroxide or iron hydroxide as adjuvant in antigen solution, and antigen solution containing such adjuvant
NZ221065A (en) Conjugates of antibodies and toxins with sulphur-containing linking groups
SE7608174L (en) PROCEDURE FOR PREPARING ANTISERUM
ES268958A1 (en) Non-toxic antigens and process for producing same
PT93178A (en) ANTICANCEROSO PROTEIN AGENT
ATE2049T1 (en) MEANS OF THERAPY OF IMMUNOCOMPLEX DISEASES.
JPS6461499A (en) Monoclonal antibody to human papilloma viruses 16 type e7 protein, and production and use thereof
JPS55141452A (en) Synthetic polypeptide
Ashcroft et al. Antibody responses to vaccination of British Guiana schoolchildren with heat-killed phenolized and acetone-killed lyophilized typhoid vaccines
ATE139701T1 (en) COMPOSITION FOR REDUCING THE SIDE EFFECTS OF A MEDICINAL PRODUCT
GB1377101A (en) Purification of gamma globulin
NL971002I1 (en) Process for the preparation of 4-amino-5-chloro-1-phenylpyridazone- (6).
GB1155683A (en) New Polyvalent Immunizing Agents and Methods for their Production
NO864382D0 (en) MEASURES FOR IMPROVING PROTEIN ABSORPTION.
KR890009417A (en) Method for producing monoclonal antibody and method of using the same